Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use

Journal Title: Epidemiology: Open Access - Year 2019, Vol 9, Issue 1

Abstract

Introduction: In 2014, Risk Minimisation Measures (RMMs) concerning thiocolchicoside for systemic use were implemented in all European countries marketing the product. A Direct Healthcare Professional Communication (DHPC) and Educational Materials (EMs), were distributed to health care professionals to increase awareness related to genotoxicity risk. Objectives: The objective of this study was to measure the effectiveness of RMMs, by ascertaining the proportion of targeted physicians who understood and implemented the latest prescribing conditions and safety information about systemic thiocolchicoside provided in the DHPC and EMs. Methods: A cross-sectional web-based survey of prescribers of systemic thiocolchicoside was conducted in France, Greece, Italy and Portugal. Sampling targets for responding physicians were determined based on country specific prescribing patterns. Frequency of correct responses was calculated for six knowledge questions and information related to recent patients’ prescriptions of TCC was analysed. Results: Among 651 responding physicians, 68.6% remembered having received either the DHPC or the EM or both. Knowledge was the highest for contraindications to the use of systemic thiocolchicoside, related to patients’ age (85.0%), pregnancy (87.6%), and lactation (80.3%) and was lower (49.1%) regarding restriction of use in women of childbearing potential not using contraception. Overall, knowledge of the right indication for use of systemic thiocolchicoside was 63.2%, while knowledge of dose and duration of treatment was higher for the oral form (78.9%) than for the injectable form (55.4%). These results were confirmed by the analysis of recent patients’ prescriptions. Knowledge varied by physician specialty and country and was higher for physicians who reported receiving either the DHPC or the EM or both. Conclusion: This study reveals geographical as well as across prescribers’ specialty contrasts in the knowledge of key messages of systemic TCC containing medicinal products associated RMMs. In addition, the results showed that when risk minimisation materials (DHPC and EM) receipt was acknowledged by physicians, it improved their knowledge and attitude towards appropriate systemic TCC prescribing to patients.

Authors and Affiliations

Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka De Voogd, Massoud Toussi

Keywords

Related Articles

Red Meat, Renal Function, Race and Other Predictors of Circulating Nitrates

Introduction: Increased levels of circulating nitrates were associated with both beneficial and adverse health outcomes in observational and intervention studies. Although more experimental studies are needed to study th...

Telomere Length in Children with Acquired Severe Aplastic Anemia

Objective: This study aimed to assess telomere length in children with severe aplastic anemia and to correlate this parameter with the response to immunosuppressive therapy Method: The study group consisted of 18 childr...

Prevalence of Malaria and Associated Factors among Febrile Patients Visiting Kalala Health Center in Haro Limmu Woreda, East Wollega Zone, Western Ethiopia, 2016

Background: Malaria is caused by protozoan parasites that belong to the Genus Plasmodium that are transmitted to human via the bite of infected female Anopheles mosquito. 34(75%) of the land mass of Ethiopia is malarious...

A Novel Tool to Evaluate the Accuracy of Predicting Survival and Guiding Lung Transplantation in Cystic Fibrosis

Background: Effective transplantation recommendations in cystic fibrosis (CF) require accurate survival predictions, so that high-risk patients may be prioritized for transplantation. In practice, decisions about transpl...

Effects of Epilepsy on Children Living in Riyadh, 2012

Background: Epilepsy affects almost 70 million people globally. Studies to assess quality of life issues among children are scant in Saudi Arabia. This study was conducted to assess physical and psychosocial aspects of l...

Download PDF file
  • EP ID EP643268
  • DOI -
  • Views 184
  • Downloads 0

How To Cite

Laurence Sophie Jouaville, Carole Ehrhardt, Marie-Laure Kürzinger, Hanka De Voogd, Massoud Toussi (2019). Evaluation of the Effectiveness of Risk Minimisation Measures Targeting Physicians on Prescribing Practices of Thiocolchicoside Containing Medicinal Products for Systemic Use. Epidemiology: Open Access, 9(1), 1-7. https://europub.co.uk/articles/-A-643268